Victor Fabano
Chief Operating Officer bij OSPY MEDI CDI
Profiel
Victor Fabano is currently working as the Vice President of Operations & Information Technology at Osprey Medical, Inc. He started this position in 2018.
Prior to his current role, he worked as the Vice President of Operations & Quality at Anulex Technologies, Inc. from 2008 to 2012.
Mr. Fabano completed his undergraduate degree at the University of North Dakota.
Actieve functies van Victor Fabano
| Bedrijven | Functie | Begin |
|---|---|---|
| OSPY MEDI CDI | Chief Operating Officer | 01-06-2012 |
Eerdere bekende functies van Victor Fabano
| Bedrijven | Functie | Einde |
|---|---|---|
Anulex Technologies, Inc.
 Anulex Technologies, Inc. Medical SpecialtiesHealth Technology Anulex Technologies, Inc. develops medical technologies. It focuses on the research and development of medical technologies to preserve and repair soft tissue of the spine for patients undergoing a surgical procedure to remove a herniated disc. The company was founded in 2001 by Matthew M. Burns and is headquartered in Minneapolis, MN. | Chief Operating Officer | 01-01-2012 |
Opleiding van Victor Fabano
| University of North Dakota | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Anulex Technologies, Inc.
Anulex Technologies, Inc. Medical SpecialtiesHealth Technology Anulex Technologies, Inc. develops medical technologies. It focuses on the research and development of medical technologies to preserve and repair soft tissue of the spine for patients undergoing a surgical procedure to remove a herniated disc. The company was founded in 2001 by Matthew M. Burns and is headquartered in Minneapolis, MN. | Health Technology |
Osprey Medical, Inc.
 Osprey Medical, Inc. Medical SpecialtiesHealth Technology Osprey Medical, Inc. engages in the development to prevent harmful effect of x-ray dye used during angiographic imaging procedures. Its product includes Dyevert system, which is designed to reduce the amount of dye contrast injected into the patients during standard cardiovascular procedures. The company was founded by Frank Solomon, David Kaye, and James Edward Shapland on August 31, 2005 and is headquartered in Minnetonka, MN. | Health Technology |
